Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors
Current Oncology · 22.05.2026 · 33 (6) · 302
DOI: 10.3390/curroncol33060302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Oncology, online erschienen am 22.05.2026. Verfasst von Emre Eken und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Türkiye. Hauptthemen laut MEDLINE: Melanoma, Neutrophils, Immune Checkpoint Inhibitors, Albumins. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although immune checkpoint inhibitors (ICIs) have improved survival in advanced melanoma, predicting individual responses remains challenging; thus, practical and inexpensive biomarkers are needed. In this study, we investigated the prognostic value of the neutrophil percentage–albumin ratio (NPAR) in patients with advanced melanoma receiving ICI therapy.
Methods
Fifty patients treated in our clinic were included, with a mean age of 53.3 years and 66% being male. Visceral metastases were present in 76% of the cohort. Through conducting Receiver Operating Characteristic (ROC) analysis, we determined an NPAR cut-off value of 1.81, with patients categorized into low (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology, Faculty of Medicine, Atatürk University, 25240 Erzurum, Türkiye.
- Department of Internal Medicine, Faculty of Medicine, Atatürk University, 25240 Erzurum, Türkiye.
ORCID-Profile: Emre Eken, Emel Ayvaz Güneyin, Elif Büyükkurt, Faruk Yıldız, Mehmet Bilici, Canan Dinar Ayman
Zitieren
APA
Eken, E., Güneyin, E. A., Büyükkurt, E., Yıldız, F., Bilici, M., & Ayman, C. D. (2026). Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. Current Oncology, 33(6), 302. https://doi.org/10.3390/curroncol33060302
Vancouver
Eken E, Güneyin EA, Büyükkurt E, Yıldız F, Bilici M, Ayman CD. Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. Current Oncology. 2026;33(6):302. doi:10.3390/curroncol33060302
BibTeX
@article{Eken2026,
author = {Eken, Emre and Güneyin, Emel Ayvaz and Büyükkurt, Elif and Yıldız, Faruk and Bilici, Mehmet and Ayman, Canan Dinar},
title = {Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors},
journal = {Current Oncology},
year = {2026},
volume = {33},
number = {6},
pages = {302},
doi = {10.3390/curroncol33060302}
}
EUVIMED